| 1. |
Morrow DA, Antman EM, Charlesworth A, et al. Timi risk score for st-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous npa for treatment of infarction myocardium early ii trial substudy [J]. Circulation, 2000, 102(17): 2031-2037.
|
| 2. |
Morrow DA, Antman EM, Parsons L, et al. Application of the timi risk score for st-elevation mi in the national registry of myocardial infarction 3[J]. JAMA, 2001, 286(11): 1356-1359.
|
| 3. |
Peterson JG, Topol EJ, Roe MT, et al. Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. Pursuit investigators. Platelet glycoprotein iib/iiia in unstable angina: Receptor suppression using integrilin therapy[J]. Am J Cardiol, 2001, 87(5): 532-536.
|
| 4. |
Brilakis ES, Wright RS, Kopecky SL, et al. Association of the pursuit risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-st-elevation acute myocardial infarction[J]. Am Heart J, 2003, 146(5): 811-818.
|
| 5. |
De Araujo Goncalves P, Ferreira J, Aguiar C, et al. Timi, pursuit, and grace risk scores: Sustained prognostic value and interaction with revascularization in nste-acs [J]. Eur Heart J, 2005, 26(9): 865-872.
|
| 6. |
Baptista SB, Farto e Abreu P, Loureiro JR, et al. Pami risk score for mortality prediction in acute myocardial indarction treated with primary angioplasty[J]. Rev Port Cardiol, 2004, 23(5): 683-693.
|
| 7. |
Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with st-elevation myocardial infarction treated with primary percutaneous coronary intervention (pami risk score) [J]. Am J Cardiol, 2004, 93(5): 629-632.
|
| 8. |
David K, Katrin H, Abraham B, et al. Development of a novel risk stratification model to improve mortality prediction in acute coronary syndromes: the AMIS (Acute Myocardial Infarction in Switzerland) model[C]. World Congress of Cardiology, 2006, September 2006.
|
| 9. |
Antman EM, Cohen M, Bernink PJ, et al. The timi risk score for unstable angina/non-st elevation mi: A method for prognostication and therapeutic decision making[J]. JAMA, 2000, 284(7): 835-842.
|
| 10. |
Szygula-Jurkiewicz B, Wilczek K, Trzeciak P, et al. [usefulness of timi risk score in assessing the prognosis in patients with acute coronary syndromes without st elevation assigned to early percutaneous coronary intervention. Comparison of the high-risk and the moderate-risk patients][J]. Pol Arch Med Wewn, 2004, 112(3): 1083-1091.
|
| 11. |
Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: The cadillac risk score[J]. J Am Coll Cardiol, 2005, 45(9): 1397-1405.
|
| 12. |
Kim HK, Jeong MH, Ahn Y, et al. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (korea acute myocardial infarction registry [kamir] score)[J]. Am J Cardiol, 2011, 107(7): 965-971.
|
| 13. |
Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes[J]. N Engl J Med, 2009, 360(21): 2165-2175.
|
| 14. |
Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-st-segment-elevation myocardial infarction: The crusade (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the acc/aha guidelines) bleeding score[J]. Circulation, 2009, 119(14): 1873-1882.
|
| 15. |
Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: An angiographic tool grading the complexity of coronary artery disease[J]. Euro Intervention, 2005, 1(2): 219-227.
|
| 16. |
Lemesle G, Bonello L, de Labriolle A, et al. Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease[J]. Catheter Cardiovasc Interv, 2009, 73(5): 612-617.
|
| 17. |
Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[J]. N Engl J Med, 2009, 360(10): 961-972.
|
| 18. |
Holzhey DM, Luduena MM, Rastan A, et al. Is the syntax score a predictor of long-term outcome after coronary artery bypass surgery?[J]. Heart Surg Forum, 2010, 13(3): 143-148.
|
| 19. |
Valgimigli M, Serruys PW, Tsuchida K, et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention[J]. Am J Cardiol, 2007, 99(8): 1072-1081.
|
| 20. |
van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention[J]. Int J Cardiol, 2009, 135(1): 60-65.
|
| 21. |
Nam CW, Mangiacapra F, Entjes R, et al. Functional syntax score for risk assessment in multivessel coronary artery disease[J]. J Am Coll Cardiol, 2011, 58(12): 1211-1218.
|
| 22. |
Garg S, Sarno G, Garcia-Garcia HM, et al. A new tool for the risk stratification of patients with complex coronary artery disease: The clinical syntax score[J]. Circ Cardiovasc Interv, 2010, 3(4): 317-326.
|
| 23. |
Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of b-type natriuretic peptide for risk assessment in unstable angina/non-st-elevation myocardial infarction: B-type natriuretic peptide and prognosis in tactics-timi 18[J]. J Am Coll Cardiol, 2003, 41(8): 1264-1272.
|
| 24. |
Jernberg T, James S, Lindahl B, et al. Natriuretic peptides in unstable coronary artery disease[J]. Eur Heart J, 2004, 25(17): 1486-1493.
|
| 25. |
Guidez T, Marechaux S, Pincon C, et al. Addition of b-type natriuretic peptide to the grace score to predict outcome in acute coronary syndrome: A retrospective (development) and prospective (validation) cohort-based study[J]. Emerg Med J, 2012, 29(4): 274-279.
|
1/5
微信公眾號